Mitochondrial metabolic rescue in post-COVID-19 syndrome: MR spectroscopy insights and precision nutritional therapeutics.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanisms and therapeutic concepts without systematic review methodology
PubMed 40486513 · doi:10.3389/fimmu.2025.1597370
What was done
This narrative review synthesized evidence on mitochondrial dysfunction in Post-COVID-19 Condition (PCC), evaluating magnetic resonance spectroscopy (MRS) biomarkers (such as τPCr and Qmax) for metabolic tracking and assessing mitochondrial-targeted nutritional therapies.
What was found
The abstract reports that PCC involves decreased adenosine triphosphate (ATP) production, elevated oxidative stress, and impaired mitochondrial biogenesis. It identifies evidence supporting nutrients such as CoQ10, NAC, and creatine for restoring energy metabolism and reducing oxidative stress. The abstract provides no specific numerical effect sizes or trial data.
Why it matters
It highlights a precision metabolic approach combining non-invasive MRS monitoring with targeted nutritional support to address persistent fatigue and bioenergetic deficits in post-COVID-19 syndrome.
Limits
As a narrative review, it presents no original empirical data. Existing literature is limited by variable nutritional regimens, unstandardized MRS methodologies, short trial durations lacking long-term outcomes, and a lack of patient stratification by baseline mitochondrial dysfunction severity.
Cited by
- supports SARS-CoV-2 enters the mitochondria and depletes cellular energy, driving long-term fatigue.